Hjem › Endometriekreft › Louisiana
Kliniske studier for Endometriekreft i Louisiana
15 studier for Endometriekreft søker deltakere på steder i Louisiana.
Byer i Louisiana
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ochsner Medical Center Jefferson, New Orleans
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05564377Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- West Jefferson Medical Center, Marrero
- East Jefferson General Hospital, Metairie
- LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 2. okt. 2026 · NCT07198074Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Ochsner Clinic Foundation, New Orleans
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT05051722Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University Medical Center New Orleans, New Orleans
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05640999A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Women's Cancer Care ( Site 6010), Covington
- TRIALS 365 ( Site 6005), Shreveport
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 17. sep. 2026 · NCT06952504A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- WK Cancer Center, Shreveport
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 17. sep. 2026 · NCT06340568ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Tulane Cancer Center, New Orleans
- Christus Highland/ Boniol, Shreveport
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- OLOL Cancer Institute, Baton Rouge
- Trials365, LLC, Shreveport
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 9. sep. 2026 · NCT07166094DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Shreveport
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 3. sep. 2026 · NCT06989112A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- LSU Health Sciences, New Orleans
- Trials365, LLC, Shreveport
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 21. aug. 2026 · NCT05548296A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Our Lady of the Lake, Baton Rouge
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT04657068Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Trials365 LLC, Shreveport
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 28. jul. 2026 · NCT07022483First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Louisiana State University Health Sciences Center, New Orleans
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Ochsner MD Anderson Cancer Center, New Orleans
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 2. jun. 2026 · NCT06730347SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.